Facebook tracking pixel
S10.AI
ICD-10-CM · D35.2GeneralSystemic

Prolactinoma

Find comprehensive information on prolactinoma diagnosis, including clinical documentation, medical coding (ICD-10 code D44.1), and healthcare resources. Learn about prolactin levels, pituitary adenoma, hyperprolactinemia symptoms, and treatment options. This resource provides valuable insights for healthcare professionals, patients, and medical coders seeking information on prolactinoma management and documentation best practices.

Also known as
Pituitary adenomaHyperprolactinemia tumor
Definition

Benign pituitary tumor that overproduces prolactin.

Clinical signs

Irregular periods, infertility, milky nipple discharge, headaches, vision changes.

Common settings

Endocrinology clinics, pituitary centers, neurosurgery departments.

Related Codes

ICD-10 Code Families

Complete code families applicable to D35.2

E22.1
Hyperprolactinemia
D35.2
Benign pituitary adenoma
G93.2
Other disorders of pituitary gland
Code Comparison

When to use each related code

DescriptionWhen to use
Benign pituitary tumor producing prolactinElevated prolactin with symptoms like galactorrhea, amenorrhea, infertility. Rule out medications, hypothyroidism.
Drug-induced hyperprolactinemiaElevated prolactin with patient taking dopamine antagonists, antipsychotics, or certain antidepressants. Consider medication review.
Primary hypothyroidismElevated prolactin with low T4/T3 and elevated TSH. TRH stimulates prolactin secretion.
Documentation

Best-practice checklist

  • Elevated prolactin level (document ng/mL)
  • Symptoms: galactorrhea, amenorrhea, infertility
  • MRI pituitary confirmation of adenoma
  • Visual field assessment (optic chiasm)
  • Differential diagnosis considerations documented
Coding & Audit Risks

Common pitfalls to avoid

Incorrect Code Specificity

Using D35.2, pituitary adenoma NOS, instead of a more specific prolactinoma code like D35.20 or D35.21 based on size/invasion.

Missed Comorbidities

Failing to code related conditions like galactorrhea (N64.3), amenorrhea (N91.2), or infertility (N97) impacting clinical care and DRG assignment.

Inconsistent Documentation

Lack of clear documentation differentiating microprolactinoma from macroprolactinoma, impacting code selection and potentially triggering audits.

Mitigation

Best-practice tips

  • 01Code hyperprolactinemia (ICD-10 E22.1) accurately for CDI, maximizing reimbursement.
  • 02Document visual field defects, headaches, galactorrhea for proper prolactinoma diagnosis coding.
  • 03Order MRI pituitary with contrast per guidelines for compliant prolactinoma diagnosis.
  • 04Rule out drug-induced hyperprolactinemia, optimizing medication reconciliation for accurate coding.
  • 05Ensure medication documentation supports diagnosis, improving CDI and healthcare compliance.
Clinical Decision Support

Step-by-step checklist

  1. 1

    Elevated prolactin level: Verify >20 ng/mL (female), >25 ng/mL (male)

  2. 2

    Rule out other causes: Drugs, hypothyroidism, pregnancy test

  3. 3

    Visual field assessment: Check for optic chiasm compression

  4. 4

    MRI pituitary: Confirm presence and size of adenoma if indicated

  5. 5

    Symptoms documented: Amenorrhea, galactorrhea, infertility, headache

Documentation Template

Ready-to-paste narrative

Patient presents with symptoms suggestive of prolactinoma, including galactorrhea, amenorrhea, oligomenorrhea, infertility, decreased libido, erectile dysfunction, and headaches.  On physical examination, galactorrhea may be present upon breast expression.  Visual field deficits may be noted depending on tumor size and compression of the optic chiasm.  Laboratory findings reveal elevated prolactin levels.  Differential diagnosis includes drug-induced hyperprolactinemia, hypothyroidism, pregnancy, and other pituitary adenomas.  Brain MRI with pituitary protocol is ordered to confirm the diagnosis and assess tumor size and location, including assessment for macroadenoma versus microadenoma.  Initial management may include dopamine agonists such as cabergoline or bromocriptine to reduce prolactin levels and tumor size.  Treatment goals focus on normalizing prolactin levels, restoring gonadal function, and improving related symptoms.  Surgical resection via transsphenoidal surgery may be considered in cases of resistance to medical therapy, significant tumor compression, or neurological symptoms.  Patient education includes discussion of medication side effects, potential complications, and the importance of regular monitoring of prolactin levels, tumor size, and visual fields.  ICD-10 code D35.2, Pituitary adenoma, is documented.  CPT codes for relevant procedures, such as MRI brain 70551 (without contrast) or 70552 (with contrast), and potentially surgery codes, will be documented upon completion of the procedures.  Continued surveillance and follow-up are crucial for long-term management of prolactinoma.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.